From: Computational drug repositioning through heterogeneous network clustering
Disease ID | Disease Name | Drug ID | Drug Name | PubMed count |
---|---|---|---|---|
H00056 | Alzheimer's disease | D09869 | Avagacestat | 5 |
H00056 | Alzheimer's disease | D08869 | Begacestat | 5 |
H00056 | Alzheimer's disease | D09377 | Semagacestat | 32 |
H00056 | Alzheimer's disease | D09010 | Tarenflurbil | 21 |
H00079 | Asthma | D09979 | Tralokinumab | 3 |
H00039 | Basal cell carcinoma | D09992 | Vismodegib | 39 |
H00728 | Brugada syndrome | D00303 | Disopyramide | 11 |
H00728 | Brugada syndrome | D08215 | Mexiletine | 17 |
H00218 | Cystic fibrosis | D09916 | Ivacaftor | 28 |
H00218 | Cystic fibrosis | D10134 | Lumacaftor | 1 |
H00937 | Familial male precocious puberty | D06247 | Triptorelin | 2 |
H00895 | Gorlin syndrome | D09992 | Vismodegib | 5 |
H00242 | Liddle syndrome | D07447 | Amiloride | 28 |
H00242 | Liddle syndrome | D00386 | Triamterene | 4 |
H00012 | Polycythemia vera | D09959 | Ruxolitinib | 19 |